A federal judge has denied BioMet’s request to get a lawsuit against the manufacturer thrown out. U.S. District Judge Robert Miller Jr. ruled that the M2a Magnum hip replacement lawsuit was still valid, despite BioMet’s claim that its use in clinical trials voided it of liability.
BioMet tried to claim “investigational device exemption” from the lawsuit, but the judge ruled that only applied to patients who were injured during the trial. Leslie Caccia alleges that the M2a metal-on-metal hip replacement caused severe injuries which required revision surgery.
BioMet faces several metal hip replacement lawsuits alleging that it released a defective device. Patients have complained of severe hip replacement side effects, including loosening of the joints, pseudo tumors, metal poisoning and tissue damage.